Phoenix, AZNCT07723963Now EnrollingIRB Ready

Juvenile Myoclonic Epilepsy Clinical Trial in Phoenix, AZ

Access cutting-edge juvenile myoclonic epilepsy treatment through this phase 2/3 clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.

Sponsored by Jazz Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Phoenix location

Preparing your pre-screening questions…

Expert Care in Phoenix

Access juvenile myoclonic epilepsy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related juvenile myoclonic epilepsy treatment provided free

Apply for This Phoenix Location

Check if you qualify for this juvenile myoclonic epilepsy clinical trial in Phoenix, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Phoenix

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Phoenix site if eligible
  4. 4Begin participation

About This Juvenile Myoclonic Epilepsy Study in Phoenix

This study is being conducted to evaluate the safety and efficacy of JZP926 capsule in participants with Juvenile Myoclonic Epilepsy (JME).

Sponsor: Jazz Pharmaceuticals

Who Can Participate

Inclusion Criteria

Participants are eligible to be included in the study only if all of the following criteria apply:
Is ≥ 10 years of age at the time of screening.
Has a diagnosis of JME per ILAE criteria as specified in the protocol.
Has at least 4 myoclonic seizure days per 28 days historical seizure frequency.

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
Presence of seizure types other than GTC, myoclonic, and absence seizures.
If historical MRI has been performed, participant's MRI reveals a cause of epilepsy other than JME.
Has a concurrent, confirmed diagnosis of non-epileptic seizures or events that can confound the assessment of the efficacy measures, in the opinion of the investigator.
The etiology of the participant's seizures is a progressive neurologic disease.
Has clinically unstable or progressive epilepsy.
Has clinically significant unstable medical condition(s), other than epilepsy, including unstable psychiatric disorders.
Has a history of status epilepticus in the 3 months prior to screening.
History of suicidal behavior, current suicidal risk as determined from history, or presence of active suicidal ideation as indicated by a positive response to Item 4 or Item 5 on the C-SSRS or is considered at risk of suicide or self-harm based on the clinical judgement of the investigator following interview with the participant and/or caregiver.
Has known or suspected hypersensitivity to cannabinoids or any of the excipients of the study intervention.
Is currently treated with Epidiolex or recently received treatment with Epidiolex within 28 days prior to screening.
Has a body weight \< 20 kg or \> 150 kg.
Is currently using or has used recreational or medicinal cannabis, cannabinoid/CBD based medications, products, or supplements (botanical or synthetic) within 28 days prior to screening.
Is unwilling or unable to abstain from recreational or medicinal cannabis, cannabinoid/CBD based medications, products, or supplements (botanical or synthetic) for the duration of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT07723963) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Juvenile Myoclonic Epilepsy Treatment Options in Phoenix, AZ

If you're searching for juvenile myoclonic epilepsy treatment options in Phoenix, AZ, this clinical trial (NCT07723963) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this phase 2/3 clinical trial. You'll receive care from experienced juvenile myoclonic epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all juvenile myoclonic epilepsy clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in Phoenix, AZ

See all epilepsy clinical trials recruiting in Phoenix — not just this study.

Browse Epilepsy Trials in Phoenix →

Browse More Trials by Condition

Epilepsy TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Phoenix?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Phoenix, AZ